In a filing, Candel Therapeutics Inc revealed its 10% Owner Aguilar-Cordova Estuardo unloaded Company’s shares for reported $90750.0 on Oct 11 ’24. In the deal valued at $6.05 per share,15,000 shares were sold. As a result of this transaction, Aguilar-Cordova Estuardo now holds 944,873 shares worth roughly $4.76 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Aguilar-Cordova Estuardo sold 15,000 shares, generating $90,300 in total proceeds. Upon selling the shares at $6.02, the 10% Owner now owns 929,873 shares.
Before that, Aguilar-Cordova Estuardo sold 10,412 shares. Candel Therapeutics Inc shares valued at $62,784 were divested by the 10% Owner at a price of $6.03 per share. As a result of the transaction, Aguilar-Cordova Estuardo now holds 919,461 shares, worth roughly $4.63 million.
H.C. Wainwright initiated its Candel Therapeutics Inc [CADL] rating to a Buy in a research note published on December 02, 2022; the price target was $11. A number of analysts have revised their coverage, including BMO Capital Markets’s analysts, who began to cover the stock in mid November with a ‘”an Outperform”‘ rating. UBS began covering CADL with “Buy” recommendation on August 23, 2021. Jefferies started covering the stock on August 23, 2021. It rated CADL as “a Buy”.
Price Performance Review of CADL
On Friday, Candel Therapeutics Inc [NASDAQ:CADL] saw its stock jump 21.89% to $5.04. Over the last five days, the stock has gained 32.63%. Candel Therapeutics Inc shares have risen nearly 242.86% since the year began. Nevertheless, the stocks have risen 460.00% over the past one year. While a 52-week high of $14.30 was reached on 05/16/24, a 52-week low of $0.77 was recorded on 01/29/24. SMA at 50 days reached $5.82, while 200 days put it at $5.68.
Levels Of Support And Resistance For CADL Stock
The 24-hour chart illustrates a support level at 4.30, which if violated will result in even more drops to 3.55. On the upside, there is a resistance level at 5.68. A further resistance level may holdings at 6.31. The Relative Strength Index (RSI) on the 14-day chart is 52.07, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.12, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 29.69%. Stochastics %K at 34.41% indicates the stock is a holding.
How much short interest is there in Candel Therapeutics Inc?
A steep rise in short interest was recorded in Candel Therapeutics Inc stocks on 2024-10-31, growing by 0.19 million shares to a total of 1.78 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 1.59 million shares. There was a rise of 10.79%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on August 23, 2021 when Credit Suisse began covering the stock and recommended ‘”an Outperform”‘ rating along with a $15 price target.
